Recombinant Peptide Biosensor Allosteric Signal Transduction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing protein-based sensors have limitations in detecting a wide range of analytes and distinguishing signal from noise, restricting their application in real-time visualization of biological events.
Innovation Solution
Development of recombinant peptide biosensors with an analyte-binding framework portion linked to a signaling portion, where the signaling portion is allosterically regulated upon interaction with a specific analyte, enabling detectable changes in signaling.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If protein-based sensors are used to detect analytes, then real-time visualization of biological events is enabled, but the range of detectable analytes is limited and signal-to-noise distinction is poor
Solution Approach 1:
The biosensor is divided into two functional segments: an analyte-binding framework portion that specifically binds to target analytes and a signaling portion that generates detectable signals. This segmentation allows independent optimization of each component - the framework for analyte specificity and the signaling portion for signal intensity and detectability, thereby expanding analyte detection range while improving signal-to-noise ratio
Solution Approach 2:
The biosensor design employs a universal framework structure (such as periplasmic binding proteins) that can be adapted to bind multiple different analytes by modifying only the binding pocket region, while maintaining the same signaling mechanism. This multi-functional approach enables a single sensor platform to detect diverse analytes including metabolites, neurotransmitters, and other biological molecules, significantly expanding the detection range
2Measurement precision
If the signaling portion is allosterically regulated by the framework portion, then specificity of analyte detection is improved, but the complexity of the biosensor structure increases
Solution Approach 1:
The biosensor employs asymmetric allosteric regulation where the framework portion and signaling portion are positioned at different locations within the molecular structure. The analyte-binding site is located in the framework portion while the signaling portion responds allosterically at a distant site, creating an asymmetric signal transduction pathway that enhances detection specificity while maintaining manageable structural complexity
Solution Approach 2:
The framework portion acts as an intermediary that translates specific analyte-binding events into conformational changes that are then transmitted to the signaling portion. This intermediary mechanism ensures that only specific analyte-framework interactions trigger signaling, improving detection specificity while the modular nature of this intermediary step keeps the overall system complexity controllable
3Strength
If a periplasmic binding protein framework is used, then conformational change upon analyte binding is enhanced, but the biosensor may be restricted to specific analyte types
Solution Approach 1:
The biosensor applies local quality modification by maintaining the robust conformational change capability of periplasmic binding proteins in the framework portion while introducing analyte-specific binding pockets with tailored chemical properties. Different binding pockets can be engineered with specific amino acid compositions to recognize different analyte types (metabolites, neurotransmitters, ions), allowing the same framework to exhibit strong conformational changes across diverse analyte classes
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The recombinant peptide biosensors effectively transduce microscopic binding events into macroscopically observable signals, enhancing the ability to detect and monitor specific analytes with improved specificity and sensitivity.
Implementation Method 1
the signaling portion is allosterically regulated by the framework portion such that signaling from the signaling portion is altered upon interaction of the framework portion with the analyte
Implementation Method 2
the signaling portion is present within the framework portion at a site or amino acid position that undergoes a conformational change upon interaction of the framework portion with a defined, specific, or selected analyte
Implementation Method 3
the signaling portion is a superfolder (SF) fluorescent protein
Data Source
AI summary
The present disclosure provides, inter alia, genetically encoded recombinant peptide biosensors comprising analyte-binding framework portions and signaling portions, wherein the signaling portions are present within the framework portions at sites or amino acid positions that undergo a conformational change upon interaction of the framework portion with an analyte.